Software - Application
Compare Stocks
5 / 10Stock Comparison
MANH vs VEEV vs HUBS vs DSGX vs NOW
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
Software - Application
Software - Application
Software - Application
MANH vs VEEV vs HUBS vs DSGX vs NOW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Medical - Healthcare Information Services | Software - Application | Software - Application | Software - Application |
| Market Cap | $8.47B | $27.03B | $10.16B | $6.22B | $94.48B |
| Revenue (TTM) | $1.10B | $3.20B | $3.30B | $731M | $13.96B |
| Net Income (TTM) | $217M | $909M | $100M | $164M | $1.76B |
| Gross Margin | 55.6% | 75.5% | 83.7% | 71.4% | 76.6% |
| Operating Margin | 25.6% | 28.7% | 1.9% | 30.4% | 13.4% |
| Forward P/E | 26.7x | 18.8x | 15.2x | 38.8x | 21.9x |
| Total Debt | $112M | $96M | $485M | $8M | $3.20B |
| Cash & Equiv. | $329M | $1.42B | $882M | $354M | $3.73B |
MANH vs VEEV vs HUBS vs DSGX vs NOW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Manhattan Associate… (MANH) | 100 | 161.8 | +61.8% |
| Veeva Systems Inc. (VEEV) | 100 | 76.0 | -24.0% |
| HubSpot, Inc. (HUBS) | 100 | 98.7 | -1.3% |
| The Descartes Syste… (DSGX) | 100 | 151.9 | +51.9% |
| ServiceNow, Inc. (NOW) | 100 | 23.5 | -76.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MANH vs VEEV vs HUBS vs DSGX vs NOW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MANH has the current edge in this matchup, primarily because of its strength in momentum and efficiency.
- -23.5% vs NOW's -90.6%
- 28.0% ROA vs HUBS's 2.7%, ROIC 236.8% vs 0.4%
VEEV is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 5.1% 10Y total return vs DSGX's 289.5%
- 28.4% margin vs HUBS's 3.0%
HUBS ranks third and is worth considering specifically for value.
- Lower P/E (15.2x vs 38.8x)
DSGX is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.65
- Lower volatility, beta 0.65, Low D/E 0.5%, current ratio 2.16x
- Beta 0.65, current ratio 2.16x
- Beta 0.65 vs NOW's 1.39, lower leverage
NOW is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 20.9%, EPS growth 21.9%, 3Y rev CAGR 22.4%
- PEG 0.32 vs DSGX's 1.51
- 20.9% revenue growth vs MANH's 3.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.9% revenue growth vs MANH's 3.7% | |
| Value | Lower P/E (15.2x vs 38.8x) | |
| Quality / Margins | 28.4% margin vs HUBS's 3.0% | |
| Stability / Safety | Beta 0.65 vs NOW's 1.39, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | -23.5% vs NOW's -90.6% | |
| Efficiency (ROA) | 28.0% ROA vs HUBS's 2.7%, ROIC 236.8% vs 0.4% |
MANH vs VEEV vs HUBS vs DSGX vs NOW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MANH vs VEEV vs HUBS vs DSGX vs NOW — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HUBS leads in 2 of 6 categories
MANH leads 1 • VEEV leads 1 • DSGX leads 1 • NOW leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
HUBS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NOW is the larger business by revenue, generating $14.0B annually — 19.1x DSGX's $731M. VEEV is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to HUBS's 3.0%. On growth, HUBS holds the edge at +23.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $3.2B | $3.3B | $731M | $14.0B |
| EBITDAEarnings before interest/tax | $288M | $956M | $166M | $310M | $2.7B |
| Net IncomeAfter-tax profit | $217M | $909M | $100M | $164M | $1.8B |
| Free Cash FlowCash after capex | $380M | $1.4B | $712M | $261M | $4.6B |
| Gross MarginGross profit ÷ Revenue | +55.6% | +75.5% | +83.7% | +71.4% | +76.6% |
| Operating MarginEBIT ÷ Revenue | +25.6% | +28.7% | +1.9% | +30.4% | +13.4% |
| Net MarginNet income ÷ Revenue | +19.7% | +28.4% | +3.0% | +22.5% | +12.6% |
| FCF MarginFCF ÷ Revenue | +34.5% | +43.7% | +21.6% | +35.8% | +33.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.4% | +16.0% | +23.4% | +17.2% | +22.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.5% | +23.9% | +2.5% | +23.3% | +2.3% |
Valuation Metrics
HUBS leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 30.6x trailing earnings, VEEV trades at a 87% valuation discount to HUBS's 229.5x P/E. Adjusting for growth (PEG ratio), NOW offers better value at 0.79x vs MANH's 1.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $8.5B | $27.0B | $10.2B | $6.2B | $94.5B |
| Enterprise ValueMkt cap + debt − cash | $8.3B | $25.7B | $9.8B | $5.9B | $94.0B |
| Trailing P/EPrice ÷ TTM EPS | 39.73x | 30.56x | 229.47x | 37.85x | 54.60x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.69x | 18.76x | 15.21x | 38.76x | 21.94x |
| PEG RatioP/E ÷ EPS growth rate | 1.85x | 1.68x | — | 1.48x | 0.79x |
| EV / EBITDAEnterprise value multiple | 28.56x | 28.05x | 55.50x | 17.82x | 36.67x |
| Price / SalesMarket cap ÷ Revenue | 7.83x | 8.46x | 3.24x | 8.35x | 7.12x |
| Price / BookPrice ÷ Book value/share | 27.74x | 3.85x | 5.08x | 3.94x | 7.36x |
| Price / FCFMarket cap ÷ FCF | 22.65x | 19.10x | 14.36x | 23.36x | 20.65x |
Profitability & Efficiency
MANH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MANH delivers a 78.2% return on equity — every $100 of shareholder capital generates $78 in annual profit, vs $5 for HUBS. DSGX carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MANH's 0.36x. On the Piotroski fundamental quality scale (0–9), DSGX scores 7/9 vs NOW's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +78.2% | +13.4% | +5.0% | +10.7% | +15.0% |
| ROA (TTM)Return on assets | +28.0% | +11.1% | +2.7% | +9.2% | +7.5% |
| ROICReturn on invested capital | +2.4% | +12.9% | +0.4% | +14.9% | +12.4% |
| ROCEReturn on capital employed | +76.3% | +13.8% | +0.5% | +15.6% | +13.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 7 | 3 |
| Debt / EquityFinancial leverage | 0.36x | 0.01x | 0.23x | 0.01x | 0.25x |
| Net DebtTotal debt minus cash | -$216M | -$1.3B | -$397M | -$346M | -$523M |
| Cash & Equiv.Liquid assets | $329M | $1.4B | $882M | $354M | $3.7B |
| Total DebtShort + long-term debt | $112M | $96M | $485M | $8M | $3.2B |
| Interest CoverageEBIT ÷ Interest expense | — | — | 6749.00x | 229.22x | 185.08x |
Total Returns (Dividends Reinvested)
VEEV leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DSGX five years ago would be worth $11,996 today (with dividends reinvested), compared to $1,953 for NOW. Over the past 12 months, MANH leads with a -23.5% total return vs NOW's -90.6%. The 3-year compound annual growth rate (CAGR) favors VEEV at -2.2% vs NOW's -40.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.5% | -24.3% | -48.4% | -15.1% | -38.2% |
| 1-Year ReturnPast 12 months | -23.5% | -30.6% | -70.1% | -33.5% | -90.6% |
| 3-Year ReturnCumulative with dividends | -15.6% | -6.3% | -55.6% | -6.5% | -79.2% |
| 5-Year ReturnCumulative with dividends | +11.2% | -33.3% | -59.4% | +20.0% | -80.5% |
| 10-Year ReturnCumulative with dividends | +144.1% | +512.1% | +359.7% | +289.5% | +35.2% |
| CAGR (3Y)Annualised 3-year return | -5.5% | -2.2% | -23.7% | -2.2% | -40.8% |
Risk & Volatility
DSGX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DSGX is the less volatile stock with a 0.65 beta — it tends to amplify market swings less than NOW's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DSGX currently trades 61.6% from its 52-week high vs NOW's 8.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.04x | 0.72x | 1.01x | 0.65x | 1.39x |
| 52-Week HighHighest price in past year | $247.22 | $310.50 | $682.57 | $117.35 | $1057.39 |
| 52-Week LowLowest price in past year | $119.06 | $148.05 | $180.50 | $62.56 | $81.24 |
| % of 52W HighCurrent price vs 52-week peak | +57.9% | +53.5% | +28.9% | +61.6% | +8.6% |
| RSI (14)Momentum oscillator 0–100 | 57.0 | 50.6 | 55.6 | 54.0 | 48.0 |
| Avg Volume (50D)Average daily shares traded | 672K | 2.3M | 1.5M | 568K | 21.1M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: MANH as "Buy", VEEV as "Buy", HUBS as "Buy", DSGX as "Buy", NOW as "Buy". Consensus price targets imply 69.0% upside for NOW (target: $154) vs 37.9% for MANH (target: $197).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $197.25 | $280.10 | $306.10 | $103.50 | $154.08 |
| # AnalystsCovering analysts | 15 | 42 | 47 | 14 | 68 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 2 | — | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.7% | +0.6% | +4.9% | +0.0% | +1.9% |
HUBS leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). MANH leads in 1 (Profitability & Efficiency).
MANH vs VEEV vs HUBS vs DSGX vs NOW: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MANH or VEEV or HUBS or DSGX or NOW a better buy right now?
For growth investors, ServiceNow, Inc.
(NOW) is the stronger pick with 20. 9% revenue growth year-over-year, versus 3. 7% for Manhattan Associates, Inc. (MANH). Veeva Systems Inc. (VEEV) offers the better valuation at 30. 6x trailing P/E (18. 8x forward), making it the more compelling value choice. Analysts rate Manhattan Associates, Inc. (MANH) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MANH or VEEV or HUBS or DSGX or NOW?
On trailing P/E, Veeva Systems Inc.
(VEEV) is the cheapest at 30. 6x versus HubSpot, Inc. at 229. 5x. On forward P/E, HubSpot, Inc. is actually cheaper at 15. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ServiceNow, Inc. wins at 0. 32x versus The Descartes Systems Group Inc. 's 1. 51x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MANH or VEEV or HUBS or DSGX or NOW?
Over the past 5 years, The Descartes Systems Group Inc.
(DSGX) delivered a total return of +20. 0%, compared to -80. 5% for ServiceNow, Inc. (NOW). Over 10 years, the gap is even starker: VEEV returned +512. 1% versus NOW's +35. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MANH or VEEV or HUBS or DSGX or NOW?
By beta (market sensitivity over 5 years), The Descartes Systems Group Inc.
(DSGX) is the lower-risk stock at 0. 65β versus ServiceNow, Inc. 's 1. 39β — meaning NOW is approximately 113% more volatile than DSGX relative to the S&P 500. On balance sheet safety, The Descartes Systems Group Inc. (DSGX) carries a lower debt/equity ratio of 1% versus 36% for Manhattan Associates, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MANH or VEEV or HUBS or DSGX or NOW?
By revenue growth (latest reported year), ServiceNow, Inc.
(NOW) is pulling ahead at 20. 9% versus 3. 7% for Manhattan Associates, Inc. (MANH). On earnings-per-share growth, the picture is similar: HubSpot, Inc. grew EPS 863. 0% year-over-year, compared to 2. 6% for Manhattan Associates, Inc.. Over a 3-year CAGR, NOW leads at 22. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MANH or VEEV or HUBS or DSGX or NOW?
Veeva Systems Inc.
(VEEV) is the more profitable company, earning 28. 4% net margin versus 1. 5% for HubSpot, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DSGX leads at 32. 3% versus 0. 4% for HUBS. At the gross margin level — before operating expenses — HUBS leads at 83. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MANH or VEEV or HUBS or DSGX or NOW more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ServiceNow, Inc. (NOW) is the more undervalued stock at a PEG of 0. 32x versus The Descartes Systems Group Inc. 's 1. 51x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, HubSpot, Inc. (HUBS) trades at 15. 2x forward P/E versus 38. 8x for The Descartes Systems Group Inc. — 23. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NOW: 69. 0% to $154. 08.
08Which pays a better dividend — MANH or VEEV or HUBS or DSGX or NOW?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is MANH or VEEV or HUBS or DSGX or NOW better for a retirement portfolio?
For long-horizon retirement investors, Veeva Systems Inc.
(VEEV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), +512. 1% 10Y return). Both have compounded well over 10 years (VEEV: +512. 1%, NOW: +35. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MANH and VEEV and HUBS and DSGX and NOW?
These companies operate in different sectors (MANH (Technology) and VEEV (Healthcare) and HUBS (Technology) and DSGX (Technology) and NOW (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MANH is a small-cap quality compounder stock; VEEV is a mid-cap high-growth stock; HUBS is a mid-cap high-growth stock; DSGX is a small-cap quality compounder stock; NOW is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.